Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InMed Pharmaceuticals (INM) Depreciation and Depletion (2019 - 2025)

InMed Pharmaceuticals has reported Depreciation and Depletion over the past 5 years, most recently at $12206.0 for Q2 2025.

  • For Q2 2025, Depreciation and Depletion rose 124.37% year-over-year to $12206.0; the TTM value through Jun 2025 reached $50204.0, up 5.16%, while the annual FY2025 figure was $50204.0, 5.16% up from the prior year.
  • Depreciation and Depletion for Q2 2025 was $12206.0 at InMed Pharmaceuticals, roughly flat from $12203.0 in the prior quarter.
  • Over five years, Depreciation and Depletion peaked at $14242.0 in Q4 2023 and troughed at $4217.0 in Q3 2021.
  • A 5-year average of $10249.0 and a median of $11394.5 in 2023 define the central range for Depreciation and Depletion.
  • Biggest five-year swings in Depreciation and Depletion: tumbled 57.88% in 2024 and later soared 124.37% in 2025.
  • Year by year, Depreciation and Depletion stood at $6246.0 in 2021, then increased by 28.98% to $8056.0 in 2022, then skyrocketed by 76.79% to $14242.0 in 2023, then dropped by 14.27% to $12209.0 in 2024, then dropped by 0.02% to $12206.0 in 2025.
  • Business Quant data shows Depreciation and Depletion for INM at $12206.0 in Q2 2025, $12203.0 in Q1 2025, and $12209.0 in Q4 2024.